Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.01
UHS's Cash to Debt is ranked lower than
51% of the 293 Companies
in the Global Medical Care industry.

( Industry Median: 0.19 vs. UHS: 0.01 )
UHS' s 10-Year Cash to Debt Range
Min: 0   Max: 0.04
Current: 0.01

0
0.04
Equity to Asset 0.42
UHS's Equity to Asset is ranked higher than
74% of the 299 Companies
in the Global Medical Care industry.

( Industry Median: 0.41 vs. UHS: 0.42 )
UHS' s 10-Year Equity to Asset Range
Min: 0.26   Max: 0.49
Current: 0.42

0.26
0.49
Interest Coverage 7.96
UHS's Interest Coverage is ranked higher than
75% of the 168 Companies
in the Global Medical Care industry.

( Industry Median: 5.33 vs. UHS: 7.96 )
UHS' s 10-Year Interest Coverage Range
Min: 4.47   Max: 25.45
Current: 7.96

4.47
25.45
F-Score: 8
Z-Score: 3.27
M-Score: -2.57
WACC vs ROIC
10.63%
10.23%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 13.18
UHS's Operating margin (%) is ranked higher than
83% of the 299 Companies
in the Global Medical Care industry.

( Industry Median: 9.77 vs. UHS: 13.18 )
UHS' s 10-Year Operating margin (%) Range
Min: 7.71   Max: 23
Current: 13.18

7.71
23
Net-margin (%) 6.76
UHS's Net-margin (%) is ranked higher than
81% of the 299 Companies
in the Global Medical Care industry.

( Industry Median: 4.94 vs. UHS: 6.76 )
UHS' s 10-Year Net-margin (%) Range
Min: 3.51   Max: 7.01
Current: 6.76

3.51
7.01
ROE (%) 15.56
UHS's ROE (%) is ranked higher than
87% of the 282 Companies
in the Global Medical Care industry.

( Industry Median: 10.46 vs. UHS: 15.56 )
UHS' s 10-Year ROE (%) Range
Min: 11.67   Max: 20.33
Current: 15.56

11.67
20.33
ROA (%) 6.31
UHS's ROA (%) is ranked higher than
83% of the 300 Companies
in the Global Medical Care industry.

( Industry Median: 4.18 vs. UHS: 6.31 )
UHS' s 10-Year ROA (%) Range
Min: 4.01   Max: 8.46
Current: 6.31

4.01
8.46
ROC (Joel Greenblatt) (%) 26.36
UHS's ROC (Joel Greenblatt) (%) is ranked higher than
80% of the 299 Companies
in the Global Medical Care industry.

( Industry Median: 20.34 vs. UHS: 26.36 )
UHS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 16.17   Max: 57.36
Current: 26.36

16.17
57.36
Revenue Growth (3Y)(%) 5.30
UHS's Revenue Growth (3Y)(%) is ranked higher than
68% of the 237 Companies
in the Global Medical Care industry.

( Industry Median: 8.30 vs. UHS: 5.30 )
UHS' s 10-Year Revenue Growth (3Y)(%) Range
Min: 5.3   Max: 19.4
Current: 5.3

5.3
19.4
EBITDA Growth (3Y)(%) 5.70
UHS's EBITDA Growth (3Y)(%) is ranked higher than
70% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. UHS: 5.70 )
UHS' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -3.3   Max: 26.7
Current: 5.7

-3.3
26.7
EPS Growth (3Y)(%) 10.30
UHS's EPS Growth (3Y)(%) is ranked higher than
75% of the 178 Companies
in the Global Medical Care industry.

( Industry Median: 10.30 vs. UHS: 10.30 )
UHS' s 10-Year EPS Growth (3Y)(%) Range
Min: -9.8   Max: 29.8
Current: 10.3

-9.8
29.8
» UHS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

UHS Guru Trades in Q1 2014

Jim Simons 81,800 sh (New)
Joel Greenblatt 426,527 sh (+189.38%)
Paul Tudor Jones 16,869 sh (+129.39%)
Manning & Napier Advisors, Inc 322,320 sh (+58.58%)
Vanguard Health Care Fund 4,259,600 sh (+9.96%)
Private Capital 406,006 sh (+1.02%)
Ron Baron 405,540 sh (unchged)
Jeremy Grantham Sold Out
Steven Cohen Sold Out
Chris Davis 145,600 sh (-1.36%)
Mariko Gordon 44,452 sh (-2.66%)
Andreas Halvorsen 2,759,799 sh (-8.31%)
Westport Asset Management 856,558 sh (-9.58%)
Ray Dalio 5,400 sh (-56.80%)
» More
Q2 2014

UHS Guru Trades in Q2 2014

Louis Moore Bacon 50,000 sh (New)
Caxton Associates 20,000 sh (New)
Larry Robbins 124,896 sh (New)
Mariko Gordon 48,682 sh (+9.52%)
Ron Baron 435,670 sh (+7.43%)
Vanguard Health Care Fund 4,484,600 sh (+5.28%)
Steven Cohen 50,000 sh (unchged)
Chris Davis 145,600 sh (unchged)
Jim Simons Sold Out
Ray Dalio Sold Out
Private Capital 393,226 sh (-3.15%)
Westport Asset Management 820,858 sh (-4.17%)
Joel Greenblatt 333,786 sh (-21.74%)
Andreas Halvorsen 1,277,443 sh (-53.71%)
Manning & Napier Advisors, Inc 125,500 sh (-61.06%)
Paul Tudor Jones 4,400 sh (-73.92%)
» More
Q3 2014

UHS Guru Trades in Q3 2014

Robert Olstein 50,000 sh (New)
RS Investment Management 222,655 sh (New)
Ken Heebner 1,045,000 sh (New)
Paul Tudor Jones 108,700 sh (+2370.45%)
Larry Robbins 406,960 sh (+225.84%)
Louis Moore Bacon 105,000 sh (+110.00%)
Mariko Gordon 48,682 sh (unchged)
Andreas Halvorsen Sold Out
Caxton Associates Sold Out
Steven Cohen Sold Out
Westport Asset Management 808,084 sh (-1.56%)
Ron Baron 416,368 sh (-4.43%)
Joel Greenblatt 300,385 sh (-10.01%)
Manning & Napier Advisors, Inc 104,940 sh (-16.38%)
Vanguard Health Care Fund 3,663,400 sh (-18.31%)
Chris Davis 116,100 sh (-20.26%)
Private Capital 255,024 sh (-35.15%)
» More
Q4 2014

UHS Guru Trades in Q4 2014

Jim Simons 159,500 sh (New)
Lee Ainslie 834,757 sh (New)
Andreas Halvorsen 514,699 sh (New)
Robert Olstein 62,000 sh (+24.00%)
Vanguard Health Care Fund 4,053,000 sh (+10.63%)
RS Investment Management 240,773 sh (+8.14%)
Chris Davis 119,100 sh (+2.58%)
Larry Robbins 406,960 sh (unchged)
Mariko Gordon 48,682 sh (unchged)
Louis Moore Bacon Sold Out
Manning & Napier Advisors, Inc Sold Out
Ken Heebner Sold Out
Ron Baron 413,228 sh (-0.75%)
Joel Greenblatt 290,283 sh (-3.36%)
Private Capital 244,224 sh (-4.23%)
Westport Asset Management 764,584 sh (-5.38%)
Paul Tudor Jones 4,840 sh (-95.55%)
» More
» Details

Insider Trades

Latest Guru Trades with UHS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK